Sfoglia per AUTORE
NAPOLEONE L
Collezione AOU Città della Salute di Torino

  

Items : 3

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial. in JAMA / JAMA. 2025 Mar 11;333(10):864-874. doi: 10.1001/jama.2024.27441.
2025
AOU Città della Salute di Torino

Pose E; Jiménez C; Zaccherini G; Campion D; Piano S; Uschner FE; de Wit K; Roux O; Gananandan K; Laleman W; Solé C; Alonso S; Cuyàs B; Ariza X; Juanola A; Ma AT; Napoleone L; Gratacós-Ginès J; Tonon M; Pompili E; Sánchez-Delgado J; Allegretti AS; Morales-Ruiz M; Carol M; Pérez-Guasch M; Fabrellas N; Pich J; Martell C; Joyera M; et alii...

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis. in Journal of hepatology / J Hepatol. 2022 Jan;76(1):107-114. doi: 10.1016/j.jhep.2021.08.031. Epub 2021 Sep 13.
2022
AOU Città della Salute di Torino

Crespo G; Solà E; Torres F; Morales-Ruiz M; Jiménez W; Pose E; Fabrellas N; Ma AT; Avitabile E; Napoleone L; Cervera M; Rubio AB; Escudé L; Bassegoda O; Pérez-Guasch M; Carol M; Solé C; Piano S; Elia C; Juanola A; Graupera I; Ginès P;

Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. in The lancet. Gastroenterology & hepatology / Lancet Gastroenterol Hepatol. 2020 Jan;5(1):31-41. doi: 10.1016/S2468-1253(19)30320-6. Epub 2019 Oct
2020
AOU Città della Salute di Torino

Kamath PS; Abraldes JG; Llopis M; Torres F; Ferrero J; Domenech G; Pich J; Carol M; Andrade RJ; Vargas V; Trebicka J; Mookerjee RP; Durand F; Caraceni P; Bernardi M; Beuers U; Alessandria C; Angeli P; Zaccherini G; de Wit K; Uschner FE; Roux O; Piano S; Jimenez C; Campion D; Amin A; Napoleone L; Pose E; Solà E; et alii...